Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Age-Related Macular Degeneration Market and Competitive Landscape 2014-2018 & 2023: Pipeline, Epidemiology, Market Valuations, Product Sales, Market Forecast, Product Forecasts, & Market Shares

Research and Markets
Posted on: 31 Oct 18
Global Age-Related Macular Degeneration Market and Competitive Landscape 2014-2018 & 2023: Pipeline, Epidemiology, Market Valuations, Product Sales, Market Forecast, Product Forecasts, & Market Shares

PR Newswire

DUBLIN, Oct. 31, 2018

DUBLIN, Oct. 31, 2018 /PRNewswire/ --

The "Global Age-Related Macular Degeneration Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering.

Global Age-Related Macular Degeneration Market and Competitive Landscape - 2018, provides comprehensive insights into Age-Related Macular Degeneration pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Age-Related Macular Degeneration market size and drug sales. This research also provides insights into Age-Related Macular Degeneration epidemiology and late stage pipeline.

The research is classified into following sections - Age-Related Macular Degeneration overview with definitions, symptoms, etiology, diagnosis, treatment options; Age-Related Macular Degeneration pipeline insights covering late stage clinical trials pipeline; Age-Related Macular Degeneration prevalence trends by countries; Age-Related Macular Degeneration market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries - US, Germany, France, Italy, Spain, UK, Japan.

Research Scope:

  • Age-Related Macular Degeneration pipeline: Find out the drugs in clinical trials for Age-Related Macular Degeneration by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Age-Related Macular Degeneration epidemiology: Find out the prevalence of Age-Related Macular Degeneration by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2023
  • Age-Related Macular Degeneration products: Identify key products marketed and prescribed for Age-Related Macular Degeneration by brand name, by molecule, by company, by branded / generic, by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Age-Related Macular Degeneration market size: Find out the market size for Age-Related Macular Degeneration drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2014
  • Age-Related Macular Degeneration drug sales: Find out the sales of Age-Related Macular Degeneration drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
  • Age-Related Macular Degeneration drugs sales forecast: Sales forecast for Age-Related Macular Degeneration drugs to 2023 by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Age-Related Macular Degeneration market share analysis: Find out the market shares of Age-Related Macular Degeneration drugs and outlook by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan

Benefits of this Research:

  • Evaluate commercial market opportunities for Age-Related Macular Degeneration drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Age-Related Macular Degeneration market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Age-Related Macular Degeneration market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies

For more information about this report visit https://www.researchandmarkets.com/research/rgdc2j/global?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-age-related-macular-degeneration-market-and-competitive-landscape-2014-2018--2023-pipeline-epidemiology-market-valuations-product-sales-market-forecast-product-forecasts--market-shares-300740587.html

SOURCE Research and Markets

PR Newswire
www.prnewswire.com

Last updated on: 31/10/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.